Seneca Biopharma

$1.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (+7.21%) Today
-$0.01 (-0.84%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SNCA and other stocks, options, and ETFs commission-free!

About SNCA

Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD. The listed name for SNCA is Seneca Biopharma, Inc. Common Stock.

CEO
Kenneth C. Carter
Employees
5
Headquarters
Germantown, Maryland
Founded
1996
Market Cap
23.36M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.43M
High Today
$1.20
Low Today
$1.05
Open Price
$1.09
Volume
2.20M
52 Week High
$2.20
52 Week Low
$0.50

SNCA Earnings

-$1.45
-$0.97
-$0.48
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 25, Pre-Market

You May Also Like

SHIPW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure